Carbohydrate fatty acid monosulphate

Carbohydrate fatty acid monosulphate has been studied in 1 paper since 2021: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Sep 9, 2021: “An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice”.

Intervention

1 paper studies it2 findingsUpdated

See all 1 papers on carbohydrate fatty acid monosulphate

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Daiichi Sankyo Europe and 8 more
  • 2 of 2 findings with company ties
  • Animals1

What did studies of carbohydrate fatty acid monosulphate find?

2

Studies of carbohydrate fatty acid monosulphate measured 2 outcomes: type I interferon signaling and antigen retention.

Type I interferon signaling

upin mice1

1 study
  1. Carbohydrate fatty acid monosulphate activates type I interferon signaling in mice.

    “CMS induced antigen retention in the draining lymph node (dLN) and expression of cytokines, chemokines and type I interferon-stimulated genes at both injection site and dLN”

    Animalsinjection site and dLN

    An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on Type I interferon signaling

Antigen retention

upin mice1

1 study
  1. Carbohydrate fatty acid monosulphate induces antigen retention in mice.

    “CMS induced antigen retention in the draining lymph node (dLN)”

    Animalsdraining lymph node

    An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

Latest